Off-target toxicity is a common mechanism of action of cancer drugs undergoing clinical trials A Lin, CJ Giuliano, A Palladino, KM John, C Abramowicz, ML Yuan, ... Science translational medicine 11 (509), eaaw8412, 2019 | 578 | 2019 |
Chromosomal instability accelerates the evolution of resistance to anti-cancer therapies DA Lukow, EL Sausville, P Suri, NK Chunduri, A Wieland, J Leu, JC Smith, ... Developmental cell 56 (17), 2427-2439. e4, 2021 | 134 | 2021 |
Oncogene-like addiction to aneuploidy in human cancers V Girish, AA Lakhani, SL Thompson, CM Scaduto, LM Brown, ... Science 381 (6660), eadg4521, 2023 | 69 | 2023 |
Chromosomal instability and aneuploidy as causes of cancer drug resistance DA Lukow, JM Sheltzer Trends in Cancer 8 (1), 43-53, 2022 | 45 | 2022 |